Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 1048 entries
View as:

Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01936233 Org: User:
Start: 08/31/13 End: 12/31/23 Due: 12/31/24

Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study（TOPS-CSVD）

Phase: N/A Priority: Normal
NCT ID: NCT06061692 Org: User:
Start: 10/31/23 End: 12/31/26 Due: 12/31/27

Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)

Phase: N/A Priority: Normal
NCT ID: NCT01380808 Org: User:
Start: 05/31/11 End: 07/31/13 Due: 07/31/14

Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00805896 Org: User:
Start: 12/31/08 End: 12/31/10 Due: 12/31/11

Radiation Dose Escalation Study for Advanced Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00848094 Org: User:
Start: 04/30/05 End: 05/31/08 Due: 05/31/09

A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06152978 Org: User:
Start: 12/15/23 End: 12/15/27 Due: 12/15/28

Use of Cyclosporin A for the Treatment of Recurrent Miscarriage

Phase: N/A Priority: Normal
NCT ID: NCT02706470 Org: User:
Start: 05/31/16 End: 12/31/18 Due: 12/31/19

Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00952679 Org: User:
Start: 01/31/09 End: 12/31/11 Due: 12/31/12

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00816816 Org: User:
Start: 02/28/07 End: 06/30/10 Due: 06/30/11

Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00525642 Org: User:
Start: 06/30/03 End: 06/30/15 Due: 06/30/16

Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04984980 Org: User:
Start: 08/01/20 End: 07/31/23 Due: 07/31/24

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT04782804 Org: User:
Start: 01/01/21 End: 05/01/24 Due: 05/01/25

A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06553846 Org: User:
Start: 08/19/24 End: 08/18/25 Due: 08/18/26

CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06281405 Org: User:
Start: 03/01/24 End: 12/31/28 Due: 12/31/29

Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05976932 Org: User:
Start: 08/31/23 End: 10/31/24 Due: 10/31/25

Is Bone Scintigraphy Necessary in cT1N0M0 GGO Non-Small Cell Lung Cancer? (ECTOP-1006)

Phase: N/A Priority: Normal
NCT ID: NCT03689439 Org: User:
Start: 12/01/18 End: 11/01/22 Due: 11/01/23

Bevacizumab Combined With Gefitinib in the Treatment of Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04425187 Org: User:
Start: 06/08/20 End: 12/31/22 Due: 12/31/23

Omics-based Precision Medicine of Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT03358459 Org: User:
Start: 11/25/17 End: 07/01/18 Due: 07/01/19

Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype

Phase: N/A Priority: Normal
NCT ID: NCT05954442 Org: User:
Start: 09/13/23 End: 08/31/26 Due: 08/31/27

Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT07001540 Org: User:
Start: 05/08/25 End: 11/15/27 Due: 11/15/28

The Antagonistic Effect of Plant Nutrients on Health Damage Caused by Environmental Pollutants

Phase: N/A Priority: Normal
NCT ID: NCT06437119 Org: User:
Start: 06/01/24 End: 08/01/24 Due: 08/01/25

Comparison of Epidural Labor Analgesia With Dexmedetomidine or Sufentanil

Phase: N/A Priority: Normal
NCT ID: NCT03622047 Org: User:
Start: 08/15/18 End: 08/01/20 Due: 08/01/21

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

Phase: N/A Priority: Normal
NCT ID: NCT00561522 Org: User:
Start: 11/30/07 End: 07/31/12 Due: 07/31/13

Oral Topotecan With Toripalimab for Patients With Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06548763 Org: User:
Start: 11/30/24 End: 12/31/26 Due: 12/31/27

Use of an Oxidized Regenerated Cellulose After Hepatic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01436721 Org: User:
Start: 08/31/11 End: 12/31/11 Due: 12/31/12